L Bèïque1, C P Por, M F Evans. Show Affiliations » 1. University of Toronto.
Abstract
Entities: Disease
Mesh： See more » Adrenergic alpha-Antagonists/administration & dosageAdrenergic alpha-Antagonists/adverse effectsAdrenergic alpha-Antagonists/therapeutic useAntihypertensive Agents/administration & dosageAntihypertensive Agents/adverse effectsAntihypertensive Agents/therapeutic useDouble-Blind MethodHumansHypotension/chemically inducedMaleMiddle AgedPlacebosProstatic Hyperplasia/drug therapyQuinazolines/administration & dosageQuinazolines/adverse effectsQuinazolines/therapeutic useSulfonamides/administration & dosageSulfonamides/adverse effectsSulfonamides/therapeutic useTamsulosin
Substances： See more » Adrenergic alpha-AntagonistsAntihypertensive AgentsPlacebosQuinazolinesSulfonamidesalfuzosinTamsulosin
Year: 1998 PMID： 9870119 PMCID： PMC2277790
Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275